ESR1 and breast carcinoma: The detection of ESR1 mutations through serial ctDNA monitoring is a hot topic now in the clinical field, since it allows for the quantitative assessment of changes in its allele frequency among patients who have advanced HR+ ​breast cancer as frontline treatment.